Developmental hemostasis. clinical implications from the fetus to the adolescent.

Pediatric Clinics of North America

Volumn 60, Issue 6, 2013, Pages 1407-1417

  Jaffray, Julie ^a   Young, Guy ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Children; Coagulation; Developmental hemostasis; Neonatal

Indexed keywords

BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 11; BLOOD CLOTTING FACTOR 13; BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 9; HEPARIN; PROTEIN C; PROTEIN S; PROTHROMBIN; THROMBIN; VITAMIN K GROUP; WARFARIN;

ADOLESCENT DEVELOPMENT; AGE DISTRIBUTION; ANTICOAGULATION; BLEEDING; BLOOD CLOTTING; BLOOD CLOTTING TEST; BLOOD CLOTTING TIME; BLOOD VESSEL WALL; CHILD DEVELOPMENT; DEVELOPMENTAL HEMOSTASIS; DEVELOPMENTAL STAGE; DISEASE CLASSIFICATION; EMBRYO DEVELOPMENT; FETUS DEVELOPMENT; FIBRIN CLOT; GESTATIONAL AGE; HEMOPHILIA A; HEMOPHILIA B; HEMOSTASIS; HUMAN; INTERNATIONAL NORMALIZED RATIO; NONHUMAN; PARTIAL THROMBOPLASTIN TIME; PATHOGENESIS; PLACENTAL TRANSFER; PROTEIN FUNCTION; PROTEIN PROCESSING; PROTHROMBIN TIME; REVIEW; THROMBOCYTE FUNCTION; THROMBOELASTOGRAPHY; THROMBOSIS; VITAMIN K DEFICIENCY; WOUND HEALING;

CHILDREN; COAGULATION; DEVELOPMENTAL HEMOSTASIS; NEONATAL;

ADOLESCENT; BLOOD COAGULATION; BLOOD COAGULATION DISORDERS; CHILD; CHILD, PRESCHOOL; FETUS; HEMOSTASIS; HUMANS;

EID: 84887610859     PISSN: 00313955     EISSN: 15578240     Source Type: Journal    
DOI: 10.1016/j.pcl.2013.08.003     Document Type: Review

References (30)

1. Kuhle S., Male C., Mitchell L. Developmental hemostasis: pro- and anticoagulant systems during childhood. Semin Thromb Hemost 2003, 29:329-338.
2. Andrew M. Developmental hemostasis: relevance to newborns and infants. Nathan and Oski's hematology of infancy and childhood 1998, 114-157. WB Saunders, Philadelphia. 5th edition. D. Nathan, S. Orkin (Eds.).
3. Kamath P., Huntington J.A., Krishnaswamy S. Ligand binding shuttles thrombin along a continuum of zymogen- and proteinase-like states. JBiol Chem 2010, 285:28651-28658.
4. Ignjatovic V., Ilhan A., Monagle P. Evidence for age-related differences in human fibrinogen. Blood Coagul Fibrinolysis 2011, 22:110-117.
5. Williams M.D., Chalmers E.A., Gibson B.E. The investigation and management of neonatal haemostasis and thrombosis. Br J Haematol 2002, 119:295-309.
6. Andrew M., Paes B., Milner R., et al. Development of the human coagulation system in the healthy premature infant. Blood 1988, 72:1651-1657.
7. Andrew M., Paes B., Milner R., et al. Development of the human coagulation system in the full-term infant. Blood 1978, 70:165-172.
8. Andrew M., Vegh B., Johnston M., et al. Maturation of the hemostatic system during childhood. Blood 1992, 80:1998-2005.
9. Manco-Johnson M.J. Development of hemostasis in the fetus. Thromb Res 2005, 115:55-63.
10. Reverdiau-Moalic P., Delahousse B., Body G., et al. Evolution of blood coagulation activators and inhibitors in the healthy human fetus. Blood 1996, 88:900-906.
11. Menashi S., Aurousseau M.H., Gozin D., et al. High levels of circulating thrombomodulin in human foetuses and children. Thromb Haemost 1999, 81:906-909.
12. Hassan H.J., Leonardi A., Chelucci C., et al. Blood coagulation factors in human embryonic-fetal development: preferential expression of the FVII/tissue factor pathway. Blood 1990, 76:1158-1164.
13. Monagle P., Barnes C., Ignjatovic V., et al. Developmental haemostasis. Impact for clinical haemostasis laboratories. Thromb Haemost 2006, 95:362-372.
14. Monagle P., Ignjatovic V., Savoia H. Hemostasis in neonates and children: pitfalls and dilemmas. Blood Rev 2010, 24:63-68.
15. Andrew M. Developmental hemostasis: relevance to thromboembolic complications in pediatric patients. Thromb Haemost 1995, 74:415-425.
16. Ignjatovic V., Mertyn E., Mongale P. The coagulation system in children: developmental and pathophysiological considerations. Semin Thromb Hemost 2011, 37:723-729.
17. Cvirn G., Gallistl S., Leschnik B., et al. Low tissue factor pathway inhibitor (Tfpi) together with low antithrombin allows sufficient thrombin generation in neonates. JThromb Haemost 2003, 1:263-268.
18. van Ommen C.H., Heijboer H., Buller H.R., et al. Venous thromboembolism in childhood: a prospective two-year registry in the Netherlands. JPediatr 2001, 139:676-681.
19. Newall F., Wallace T., Crock C., et al. Venous thromboembolic disease: a single center case series study. JPaediatr Child Health 2006, 42:803-807.
20. Strauss T., Levy-Shraga Y., Ravid B., et al. Clot formation of neonates tested by thromboelastography correlates with gestational age. Thromb Haemost 2010, 103:344-350.
21. Mitchell L., Piovella F., Ofosu F., et al. Alpha-2-macroglobulin may provide protection from thromboembolic events in antithrombin III-deficient children. Blood 1991, 78:2299-2304.
22. Lippi G., Franchini M., Montagnana M., et al. Coagulation testing in pediatric patients: the young are not just miniature adults. Semin Thromb Hemost 2007, 33:816-820.
23. Saxonhouse M.A., Manco-Johnson M.J. The evaluation and management of neonatal coagulation disorders. Semin Perinatol 2009, 33:52-65.
24. Shearer M.J. Vitamin K deficiency bleeding (Vkdb) in early infancy. Blood Rev 2009, 23:49-59.
25. Chalmers E.A. Haemophilia and the newborn. Blood Rev 2004, 18:85-92.
26. Young G. New anticoagulants in children: a review of recent studies and a look to the future. Thromb Res 2011, 127:70-74.
27. Hirsh J., Bauer K.A., Donati M.B., et al. Anticoagulants: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition). Chest 2008, 133:1415-1595.
28. Ignjatovic V., Furmedge J., Newall F., et al. Age-related differences in heparin response. Thromb Res 2006, 118:741-745.
29. Hirsh J., Dalen J., Anderson D.R., et al. Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range. Chest 2001, 119:85-215.
30. Massicotte P., Leaker M., Marzinotto V., et al. Enhanced thrombin regulation during warfarin therapy in children compared to adults. Thromb Haemost 1998, 80:570-574.